The 10 key players our Point Of Care (PoC) Molecular Diagnostic report profiles, and other companies free public records show in this market.
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | Abbott Laboratories | — | 2,310 reports |
| 2 | Roche Diagnostics |
roche-diagnostics.ch (opens in a new tab) | 924 reports |
| 3 | Cepheid |
cepheid.com (opens in a new tab) | 231 reports |
| 4 | Thermo Fisher Scientific Inc. | — | 1,023 reports |
| 5 | bioMérieux SA | — | 462 reports |
| 6 | Quidel Corporation | — | 198 reports |
| 7 | Danaher Corporation | — | 231 reports |
| 8 | Siemens Healthineers |
siemens-healthineers.com (opens in a new tab) | 1,155 reports |
| 9 | Hologic, Inc. |
hologic.com (opens in a new tab) | 264 reports |
| 10 | Grifols | — | 132 reports |
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: FDA 510(k) and PMA databases, 510(k) clearances and PMA approvals since 2015 for devices whose name has this market's words. Retrieved 13 Nov 2026.
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
One report for each place. Each tile opens that place's report.
Compare all 33 places for Point Of Care (PoC) Molecular Diagnostic, with active trials
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.